Senti Biosciences, Inc. financial data

Symbol
SNTI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2 Corporate Drive, First Floor, South San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Dynamics Special Purpose Corp. (to 6/13/2022)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 629 % -9.11%
Debt-to-equity 63.9 % +70.7%
Return On Equity -154 % -95.6%
Return On Assets -94 % -64.1%
Operating Margin -7.38K % -405%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.8M shares +3.59%
Common Stock, Shares, Outstanding 45.7M shares +3.72%
Entity Public Float 30.2M USD
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 45.7M shares +3.72%
Weighted Average Number of Shares Outstanding, Diluted 45.7M shares +3.72%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.28M USD -71.5%
Revenue from Contract with Customer, Excluding Assessed Tax 942K USD -72.8%
Research and Development Expense 33.9M USD +22.7%
General and Administrative Expense 35.5M USD -15.8%
Operating Income (Loss) -94.1M USD -44.1%
Nonoperating Income (Expense) 12.4M USD -8.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -117M USD -11.1%
Earnings Per Share, Basic -1.44 USD/shares -235%
Earnings Per Share, Diluted -1.44 USD/shares -235%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 23.7M USD -24.9%
Cash, Cash Equivalents, and Short-term Investments 35.9M USD -63.6%
Accounts Receivable, after Allowance for Credit Loss, Current 567K USD
Other Assets, Current 0 USD -100%
Assets, Current 55.7M USD -30.9%
Property, Plant and Equipment, Net 24.4M USD -58.7%
Operating Lease, Right-of-Use Asset 15.8M USD -11.8%
Other Assets, Noncurrent 86K USD -81.7%
Assets 102M USD -36.7%
Accounts Payable, Current 1.62M USD -37.1%
Employee-related Liabilities, Current 888K USD -50.6%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 9.61M USD -25.3%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 32.4M USD -9.54%
Liabilities 46.1M USD -6.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -256M USD -33.6%
Stockholders' Equity Attributable to Parent 56.1M USD -50.1%
Liabilities and Equity 102M USD -36.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.7M USD +28.3%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 30.1M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 45.7M shares +3.72%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.7M USD +54.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 27.8M USD -21.1%
Deferred Tax Assets, Valuation Allowance 61.3M USD +45.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 64.8M USD +41.1%
Operating Lease, Liability 36.6M USD -3.43%
Depreciation 984K USD +111%
Payments to Acquire Property, Plant, and Equipment 15K USD -99.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -64.5M USD +1.03%
Lessee, Operating Lease, Liability, to be Paid 50.8M USD -12.2%
Property, Plant and Equipment, Gross 31.5M USD -49.6%
Operating Lease, Liability, Current 4.18M USD +103%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.71M USD +3.13%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.48M USD +3.09%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14.2M USD -19.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.77M USD -25.2%
Deferred Tax Assets, Operating Loss Carryforwards 33.6M USD +32.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.08M USD +26.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.86M USD -15.8%
Additional Paid in Capital 313M USD +2.7%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 9.36M USD -49.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%